The novel approach of tirzepatide peptide represents a exciting development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects dual pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide587910.bloginder.com/42638479/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment